Table 3.
Symptom severity and health-related quality of life at baseline and follow-up after transcervical resection of the endometrium.
| Baseline (n = 112) | 6 months follow-up (n = 105)1 | 6 months improvement | 18 months follow-up (n = 96)2 | 18 months improvement | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Median | 75% PI | N | Median | 75% PI | Mean | 95% CI | Difference | N | Median | 75% PI | Mean | 95% CI | Difference | |
| SSS | |||||||||||||||
| Adenomyosis of the inner myometrium | 24 | 59.4 | 48-66 | 22 | 18.8 | 9-44 | 34.4 | 25-44 | p-value >.05* | 15 | 18.8 | 6-19 | 39.8 | 30-50 | p-value > .05 |
| Serrated junctional zone | 31 | 50.0 | 34-63 | 29 | 9.4 | 6-25 | 33.4 | 25-41 | 28 | 10.9 | 3-19 | 35.0 | 28-42 | ||
| Linear junctional zone | 57 | 56.3 | 44-72 | 54 | 7.8 | 0-25 | 41.6 | 35-48 | 53 | 9.4 | 3-22 | 42.3 | 36-48 | ||
| HR-QoL total | |||||||||||||||
| Adenomyosis of the inner myometrium | 24 | 56.5 | 46-63 | 22 | 85.8 | 69-91 | 22.9 | 17-29 | p-value ≤ .05 | 15 | 90.5 | 76-95 | 28.6 | 21-37 | p-value > .05 |
| Serrated junctional zone | 31 | 56.0 | 42-66 | 29 | 93.1 | 83-97 | 31.0 | 22-40 | 28 | 93.1 | 80-97 | 30.7 | 22-39 | ||
| Linear junctional zone | 57 | 49.1 | 40-63 | 54 | 94.0 | 84-98 | 36.3 | 31-41 | 53 | 92.2 | 86-98 | 35.4 | 29-42 | ||
SSS: Symptom severity score. HR-QoL: Health-Related Quality of Life. PI: Percentile interval, CI: Confidence interval.
No subscale score was considered missing.
1 6 months follow-up questionnaire missing in four patients (these patients did not have surgical reintervention), three patients excluded due to reintervention surgery within the follow-up period.
2 18 months follow-up questionnaire missing in six patients (one of the patients had reintervention), ten patients exclude due to reintervention surgery within the follow-up period.
No statistically significant difference in baseline SSS and HR-QoL between the groups (p-value > 0.05).
*Statistically significant difference in 6 months follow-up SSS and HR-QoL between patients with either serrated junctional zone or adenomyosis of the inner myometrium and linear junctional zone (p-value ≤ .05).